A Clinical Study of Enlicitide and the Effect of Food in Healthy Adult Participants (MK-0616-033)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 21, 2024

Primary Completion Date

January 13, 2025

Study Completion Date

January 31, 2025

Conditions

Healthy

Interventions

DRUG

Enlicitide

Oral Tablet

Trial Locations (1)

Celerion ( Site 0001), Tempe

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06609512 - A Clinical Study of Enlicitide and the Effect of Food in Healthy Adult Participants (MK-0616-033) | Biotech Hunter | Biotech Hunter